Shruti Drugs Private Limited, a active private limited company, was established on 11 July 1994 in Secunderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230TG1994PTC017903. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.25 Cr and a paid-up capital of ₹1.86 Cr.
Formerly known as Shruti Bulk Drugs Pvt Ltd,, Shruti Bulk Drugs Pvt Ltd. It upholds a compliant status. Its leadership includes Prakash Praveen Chandra Kadakia (Director), Nishit Prakash Chandra Kadakia (Director). Past directors included Mukesh Hiralal Gandhi. It holds ₹36.17 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5-4-187/7-3, Mahatma Gandhi Road, Secunderabad, Telangana, 500003.
U24230TG1994PTC017903
017903
11 July 1994
₹2.25 Cr
₹1.86 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Shruti Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Praveen Chandra Kadakia | Director | 24 Jul 1994 | Current |
| Nishit Prakash Chandra Kadakia | Director | 29 Jul 1994 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 09 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shruti Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.62% increase. The company also saw a substantial improvement in profitability, with a 96.68% increase in profit. The company's net worth Soared by an impressive increase of 18.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shruti Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹361,730,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2024 | Others | ₹6.50 Cr | Open |
| 29 Jun 2022 | Hdfc Bank Limited | ₹2.00 M | Open |
| 08 Jul 2020 | Others | ₹14.62 Cr | Open |
| 03 Nov 2016 | Others | ₹7.00 M | Open |
| 03 Nov 2016 | Others | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shruti Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shruti Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shruti Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shruti Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Shruti Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
A charge with Others amounted to Rs. 6.50 Cr with Charge ID 100924961 was registered on 20 Apr 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 14.62 Cr registered on 08 Jul 2020 with Charge ID 100398999 was modified on 10 Apr 2024. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100759876 was registered on 29 Jun 2022. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 14.62 Cr with Charge ID 100398999 was registered on 08 Jul 2020. was completed.
The CIN of Shruti Drugs Private Limited is U24230TG1994PTC017903.
Shruti Drugs Private Limited is headquartered at 5-4-187/7-3, Mahatma Gandhi Road, Secunderabad, Telangana, 500003.
Shruti Drugs Private Limited was incorporated on 11 July 1994.
The current directors of Shruti Drugs Private Limited are
The primary industry of Shruti Drugs Private Limited is Manufacturing.
Shruti Drugs Private Limited is unlisted.
The authorized capital of Shruti Drugs Private Limited is ₹2.25 Cr, and the paid-up capital is ₹1.86 Cr.
The compliance status of Shruti Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX